Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men

Journal of the American College of Cardiology

Volumn 64, Issue 17, 2014, Pages 1801-1810

  Tivesten, Åsa ^a   Vandenput, Liesbeth ^b   Carlzon, Daniel ^b   Nilsson, Maria ^b   Karlsson, Magnus K ^c   Ljunggren, Östen ^d   Barrett Connor, Elizabeth ^e   Mellström, Dan ^b   Ohlsson, Claes ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular disease; dehydroepiandrosterone; men

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; ESTRADIOL; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ACUTE HEART INFARCTION; ADULT; AGE; ANDROGEN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; SMOKING; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; AGED; BLOOD; CLINICAL TRIAL; CORONARY DISEASE; GAS CHROMATOGRAPHY; KAPLAN MEIER METHOD; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SWEDEN; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, LIQUID; CORONARY DISEASE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SWEDEN; TREATMENT OUTCOME;

EID: 84908193694     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.05.076     Document Type: Article

References (54)

1. A.M. Traish, H.P. Kang, and F. Saad Dehydroepiandrosterone (DHEA)-A precursor steroid or an active hormone in human physiology J Sex Med 8 2011 2960 2982 quiz 2983
2. S.J. Webb, T.E. Geoghegan, and R.A. Prough The biological actions of dehydroepiandrosterone involves multiple receptors Drug Metab Rev 38 2006 89 116
3. S. Bonnet, R. Paulin, and G. Sutendra Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis Circulation 120 2009 1231 1240
4. F. Labrie, V. Luu-The, and A. Belanger Is dehydroepiandrosterone a hormone? J Endocrinol 187 2005 169 196
5. G. Zhai, A. Teumer, and L. Stolk Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms PLoS Genet 7 2011 e1002025
6. A. Tchernof, and F. Labrie Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies Eur J Endocrinol 151 2004 1 14
7. J. Hazeldine, W. Arlt, and J.M. Lord Dehydroepiandrosterone as a regulator of immune cell function J Steroid Biochem Mol Biol 120 2010 127 136
8. P. Alexandersen, J. Haarbo, and I. Byrjalsen Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits Circ Res 84 1999 813 819
9. J.P. Camporez, E.H. Akamine, and A.P. Davel Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats J Physiol 589 2011 2585 2596
10. A.Z. LaCroix, K. Yano, and D.M. Reed Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men Circulation 86 1992 1529 1535
11. J. Slowinska-Srzednicka, S. Zgliczynski, and M. Ciswicka-Sznajderman Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction Atherosclerosis 79 1989 197 203
12. L.E. Mitchell, D.L. Sprecher, and I.B. Borecki Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males Circulation 89 1994 89 93
13. C.S. Contoreggi, M.R. Blackman, and R. Andres Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men J Androl 11 1990 460 470
14. L.M. Newcomer, J.E. Manson, and R.L. Barbieri Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study Am J Epidemiol 140 1994 870 875
15. S.M. Haffner, S.E. Moss, and B.E. Klein Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy Diabetes Care 19 1996 1045 1050
16. C. Ohlsson, F. Labrie, and E. Barrett-Connor Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men J Clin Endocrinol Metab 95 2010 4406 4414
17. D.P. Trivedi, and K.T. Khaw Dehydroepiandrosterone sulfate and mortality in elderly men and women J Clin Endocrinol Metab 86 2001 4171 4177
18. E. Barrett-Connor, K.T. Khaw, and S.S. Yen A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease N Engl J Med 315 1986 1519 1524
19. E. Barrett-Connor, and D. Goodman-Gruen The epidemiology of DHEAS and cardiovascular disease Ann N Y Acad Sci 774 1995 259 270
20. A.C. Phillips, D. Carroll, and C.R. Gale Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study Eur J Endocrinol 163 2010 285 292
21. C. Marx, S. Petros, and S.R. Bornstein Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol Crit Care Med 31 2003 1382 1388
22. R.H. Straub, M. Cutolo, and F. Buttgereit Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases J Int Med 267 2010 543 560
23. H.A. Feldman, C.B. Johannes, and A.B. Araujo Low dehydroepiandrosterone and ischemic heart disease in middle-Aged men: prospective results from the Massachusetts Male Aging Study Am J Epidemiol 153 2001 79 89
24. A. Tivesten, L. Vandenput, and F. Labrie Low serum testosterone and estradiol predict mortality in elderly men J Clin Endocrinol Metab 94 2009 2482 2488
25. E. Orwoll, J.B. Blank, and E. Barrett-Connor Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-A large observational study of the determinants of fracture in older men Contemp Clin Trials 26 2005 569 585
26. M. Flodin, A.S. Jonsson, and L.O. Hansson Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L Scand J Clin Lab Invest 67 2007 560 567
27. F. Labrie, A. Belanger, and P. Belanger Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women J Steroid Biochem Mol Biol 99 2006 182 188
28. L. Vandenput, F. Labrie, and D. Mellstrom Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men J Bone Miner Res 22 2007 220 227
29. E.S. Orwoll, C.M. Nielson, F. Labrie for the Osteoporotic Fractures in Men (MrOS) Research Group Evidence for geographical and racial variation in serum sex steroid levels in older men J Clin Endocrinol Metab 95 2010 E151 E160
30. J. Merlo, U. Lindblad, and H. Pessah-Rasmussen Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers Eur J Epidemiol 16 2000 235 243
31. P.M. Grambsch, and T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
32. S. Durrleman, and R. Simon Flexible regression models with cubic splines Stat Med 8 1989 551 561
33. G. Claeskens, and N.L. Hjort Cambridge series in statistical and probabalistic mathematics: model selection and model averaging 2008 Cambridge University Press Cambridge, UK
34. G.V. Avvakumov, A. Cherkasov, and Y.A. Muller Structural analyses of sex hormone-binding globulin reveal novel ligands and function Mol Cell Endocrinol 316 2010 13 23
35. J. Arnlov, M.J. Pencina, and S. Amin Endogenous sex hormones and cardiovascular disease incidence in men Ann Intern Med 145 2006 176 184
36. A.H. Payne, and D.B. Hales Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones Endocrine Rev 25 2004 947 970
37. H. Kawano, H. Yasue, and A. Kitagawa Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men J Clin Endocrinol Metab 88 2003 3190 3195
38. M.R. Williams, T. Dawood, and S. Ling Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors J Clin Endocrinol Metab 89 2004 4708 4715
39. J.J. Christiansen, N.H. Andersen, and K.E. Sorensen Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status Clin Endocrinol (Oxf) 66 2007 426 433
40. S.P. Rice, N. Agarwal, and H. Bolusani Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial J Clin Endocrinol Metab 94 2009 1966 1972
41. D.T. Villareal, and J.O. Holloszy Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial JAMA 292 2004 2243 2248
42. K.S. Nair, R.A. Rizza, and P. O'Brien DHEA in elderly women and DHEA or testosterone in elderly men N Engl J Med 355 2006 1647 1659
43. C.M. Jankowski, W.S. Gozansky, and R.S. Schwartz Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial J Clin Endocrinol Metab 91 2006 2986 2993
44. D. von Muhlen, G.A. Laughlin, and D. Kritz-Silverstein Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial Osteoporos Int 19 2008 699 707
45. V. Sherk, C. Jankowski, and S. Khosla Sex-specific effects of DHEA supplementation on bone mineral density and body composition: a pooled analysis of four randomized controlled trials (abstr) J Bone Miner Res Suppl 1 2012 27
46. D. Liu, and J.S. Dillon Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3) J Biol Chem 277 2002 21379 21388
47. D. Liu, M. Iruthayanathan, and L.L. Homan Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms Endocrinology 149 2008 889 898
48. M.R. Williams, S. Ling, and T. Dawood Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs J Clin Endocrinol Metab 87 2002 176 181
49. M. Ii, M. Hoshiga, and N. Negoro Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury Atherosclerosis 206 2009 77 85
50. P. Boudou, C. Naret, and J. Fiet Accumulation of 5 alpha-reduced androgen glucosiduronates associated with impaired removal in young male hemodialysis patients J Clin Endocrinol Metab 80 1995 3489 3493
51. F. Hammer, S. Subtil, and P. Lux No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA and in vitro studies J Clin Endocrinol Metab 90 2005 3600 3605
52. W. Arlt, F. Hammer, and P. Sanning Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock J Clin Endocrinol Metab 91 2006 2548 2554
53. W.E. Rainey, and Y. Nakamura Regulation of the adrenal androgen biosynthesis J Steroid Biochem Mol Biol 108 2008 281 286
54. S. Oudard Progress in emerging therapies for advanced prostate cancer Cancer Treat Rev 39 2013 275 289